Clik here to view.
Article 3
Scientists have identified a new way to stop malaria parasites from multiplying, an important step in developing new treatments for the disease, which killed an estimated 1.2 million people in 2010.The...
View ArticleClik here to view.
Exploiting DNA Damage
Exploiting DNA DamageSepantronium bromide holds promises as a selective genotoxic drug for cancer treatmentRead morehttp://www.chemistryviews.org/details/news/6467801/Exploiting_DNA_Damage.html
View ArticleClik here to view.
Antibody-Free Detection
Antibody-Free DetectionGraphene oxide photoluminescence can be modulated to allow detection of neurotransmittersRead morehttp://www.chemistryviews.org/details/news/6467951/Antibody-Free_Detection.html
View ArticleClik here to view.
Size and Shape Matter
Size and Shape MatterSpecial nanoparticle structures measured by light scatteringRead morehttp://www.chemistryviews.org/details/ezine/6463921/Size_and_Shape_Matter.html
View ArticleClik here to view.
Clik here to view.
Traditional medicine-inspired approaches to drug discovery: can Ayurveda show...
Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?B Patwardhan, RA Mashelkar - Drug discovery today, 2009 - ElsevierDrug discovery strategies based on...
View ArticleClik here to view.
Drug-drug co-crystals.
Figure 1Representation of drug-drug co-crystal and combination drug. Active pharmaceutical ingredients (APIs) are most conveniently developed and delivered orally as solid dosage forms that contain...
View ArticleClik here to view.
Dissolution properties, solid-state transformation and polymorphic...
Progesterone is a natural steroid hormone and a poor soluble drug which presents two polymorphs (forms 1 and 2). Different methods to obtain form 2 were tested and a complete solid-state...
View ArticleClik here to view.
FDA approves new drug Cerdelga (eliglustat) to treat a form of Gaucher disease
August 19, 2014ReleaseThe U.S. Food and Drug Administration today approved Cerdelga (eliglustat) for the long-term treatment of adult patients with the Type 1 form of Gaucher disease, a rare genetic...
View ArticleClik here to view.
Glenmark enters Oncology with the Discovery and the Initiation of IND...
August20,2014: GlenmarkPharmaceuticalsS.A.(GPSA),awhollyownedsubsidiaryofGlenmarkPharmaceuticalsLimitedIndia(GPL),announcesthediscovery...
View ArticleClik here to view.
FDA Approves Arnuity Ellipta
FDA Approves Arnuity Ellipta (fluticasone furoate) for the Treatment of Asthma 20 August 2014 -- GlaxoSmithKline plc today announced that the Food and Drug Administration has approved Arnuity™ Ellipta®...
View ArticleClik here to view.
FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis and...
Thursday, August 21, 2014 - Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved a Supplemental New Drug...
View ArticleClik here to view.
Plerixafor..............an immunostimulant used to mobilize hematopoietic...
Plerixaforcas 110078-46-1CXCR4 chemokine antagonistStem cell mobilization [CXCR4 receptor antagonist]A bicyclam derivate, highly potent & selective inhibitor of HIV-1 & HIV-2.Bone marrow...
View ArticleClik here to view.
FDA allows marketing of first ZnT8Ab autoantibody test to help diagnose type...
Today, August 20, 2014, the U.S. Food and Drug Administration allowed marketing of the first zinc transporter 8 autoantibody (ZnT8Ab) test that can help determine if a person has type 1 diabetes and...
View ArticleClik here to view.
Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of...
Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of Osteoarthritis Pain August 25, 2014 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing...
View ArticleClik here to view.
FDA Gives Insys Pharmaceutical Cannabidiol Orphan Status
Insys Therapeutics Inc., a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, announced that the U.S. Food and Drug Administration...
View ArticleClik here to view.
Situation Analysis of R & D Activities: An Empirical Study in Iranian...
Volume & Issue: Volume 11, Issue 4, Autumn 2012, Page 999-1290 Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical CompaniesHamid Reza Rasekh; Gholamhossein...
View ArticleClik here to view.
GSK receives FDA approval for Promacta
Dr Paolo Paoletti, president, Oncology, GSKGlaxoSmithKline (GSK) announced that the USFDA has approved a supplemental New Drug Application (sNDA) for the once-daily use of Promacta (eltrombopag) in...
View ArticleClik here to view.
Idarubicin hydrochloride
Idarubicin hydrochloride NSC-256439, IMI-30, DMDR, Idamycin, Zavedos Idarubicin /ˌaɪdəˈruːbɨsɪn/ or 4-demethoxydaunorubicin is an anthracyclineantileukemic drug. It inserts itself into DNA and...
View ArticleClik here to view.
Drug Assembly On-Site... Drug Delivery: Click reaction links small molecules...
When a number of derivatized small-molecule inhibitors bind to an RNA repeat sequence in cells, their alkyne and azide groups react with one another, producing potent oligomers.If a multicomponent...
View Article